Literature DB >> 20166965

Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research.

Gunnar P H Dietz1.   

Abstract

Cell-penetrating peptides (CPP), also called protein transduction domains (PTD), membrane-permeable peptides (MPP), or Trojan horse peptides, have been used in many different research areas. The delivery of heat shock proteins (Hsp) using CPP has been applied in models for apoptosis, necrosis, oxidative stress, neurodegenerative diseases, stroke, cystic fibrosis, smooth muscle relaxation, myocardial injury, scar formation, and others. This review summarizes the accomplishments of the field over the last years and discusses why Hsp are particularly suitable for CPP-mediated delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166965     DOI: 10.2174/138920110790909731

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  19 in total

Review 1.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

2.  Transport of the synthetic opioid peptide DADLE ([D-Ala2,D-Leu5]-enkephalin) in neuronal cells.

Authors:  Sudha Ananth; Santoshanand V Thakkar; Jaya P Gnana-Prakasam; Pamela M Martin; Preethi S Ganapathy; Sylvia B Smith; Vadivel Ganapathy
Journal:  J Pharm Sci       Date:  2011-09-08       Impact factor: 3.534

3.  Cooperative, heparan sulfate-dependent cellular uptake of dimeric guanidinoglycosides.

Authors:  Andrew V Dix; Lucile Fischer; Stéphane Sarrazin; Christopher P H Redgate; Jeffrey D Esko; Yitzhak Tor
Journal:  Chembiochem       Date:  2010-11-02       Impact factor: 3.164

Review 4.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

5.  Chlorogenic Acid Improves Neuroprotective Effect of PEP-1-Ribosomal Protein S3 Against Ischemic Insult.

Authors:  Eun Hee Ahn; Dae Won Kim; Min Jea Shin; Soon Won Kwon; Young Nam Kim; Duk-Soo Kim; Soon Sung Lim; Joon Kim; Jinseu Park; Won Sik Eum; Hyun Sook Hwang; Soo Young Choi
Journal:  Exp Neurobiol       Date:  2011-12-29       Impact factor: 3.261

6.  Tat-antioxidant 1 protects against stress-induced hippocampal HT-22 cells death and attenuate ischaemic insult in animal model.

Authors:  So Mi Kim; In Koo Hwang; Dae Young Yoo; Won Sik Eum; Dae Won Kim; Min Jea Shin; Eun Hee Ahn; Hyo Sang Jo; Eun Ji Ryu; Ji In Yong; Sung-Woo Cho; Oh-Shin Kwon; Keun Wook Lee; Yoon Shin Cho; Kyu Hyung Han; Jinseu Park; Soo Young Choi
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

7.  Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse model.

Authors:  Dae Won Kim; Sung Ho Lee; Sae Kwang Ku; Soo Hyun Cho; Sung-Woo Cho; Ga Hyeon Yoon; Hyun Sook Hwang; Jinseu Park; Won Sik Eum; Oh-Shin Kwon; Soo Young Choi
Journal:  BMB Rep       Date:  2013-02       Impact factor: 4.778

8.  Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury.

Authors:  Hoon Jae Jeong; Dae Won Kim; Mi Jin Kim; Su Jung Woo; Hye Ri Kim; So Mi Kim; Hyo Sang Jo; Hyun Sook Hwang; Duk Soo Kim; Sung Woo Cho; Moo Ho Won; Kyu Hyung Han; Jin Seu Park; Won Sik Eum; Soo Young Choi
Journal:  Exp Mol Med       Date:  2012-10-31       Impact factor: 8.718

9.  The effects of PEP-1-FK506BP on dry eye disease in a rat model.

Authors:  Dae Won Kim; Sung Ho Lee; Sae Kwang Ku; Ji Eun Lee; Hyun Ju Cha; Jong Kyu Youn; Hyeok Yil Kwon; Jong Hoon Park; Eun Young Park; Sung-Woo Cho; Kyu Hyung Han; Jinseu Park; Won Sik Eum; Soo Young Choi
Journal:  BMB Rep       Date:  2015-03       Impact factor: 4.778

10.  PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model.

Authors:  Mi Jin Kim; Hoon Jae Jeong; Dae Won Kim; Eun Jeong Sohn; Hyo Sang Jo; Duk-Soo Kim; Hyun Ah Kim; Eun Young Park; Jong Hoon Park; Ora Son; Kyu Hyung Han; Jinseu Park; Won Sik Eum; Soo Young Choi
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.